Navigation Links
Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes'
Date:4/30/2009

Register for an Educational Webinar "How Organizations Can Make the Transition to SPL R4 Compliance," Hosted by Pilgrim Software and featuring Virtify, Inc.

CAMBRIDGE, Mass., April 30 /PRNewswire/ -- Virtify, Inc. (www.virtify.com), the market leader in Enterprise Content Compliance solutions for life sciences, and Pilgrim Software (www.pilgrimsoftware.com), a provider of Enterprise Compliance and Quality Management (ECQM) software solutions, will host a complimentary Webinar on best practices in SPL R4 compliance and how organizations can make the necessary transitions required by the new June 2009 mandate. The Webinar will take place on Thursday, May 7th at 11:00 a.m. EDT and feature Dr. Satish Tadikonda, founder and president of Virtify, Inc. This Webinar is for all human health, animal health, biologics and vaccines organizations and medical device companies who are modifying in-house systems or evaluating new technologies to meet the new SPL R4 requirements. The webinar is designed as a "how to" primer on complying with SPL R4.

Attendees will learn about:

  • Best practices for complying with SPL R4
  • Accelerating the conversion process from SPL R3 submissions to SPL R4 submissions
  • Automating the information transfer to SPL XML structure
  • Managing the changes involved with SPL R4 and streamlining submissions planning, preparation and tracking
  • Performing in-depth validation and QC for SPL R4 information

Title: "Best Practices for SPL R4 Compliance for Life Sciences Companies - Are You Ready for the June 2009 Mandate?"

Presenter: Dr. Satish Tadikonda, founder and president, Virtify, Inc.

Date/Time: Thursday, May 7 at 11:00 am EDT

To Register: https://pilgrim.webex.com/pilgrim/onstage/g.php?t=a&d=483923144

About Dr. Tadikonda

Dr. Tadikonda is founder and president of Virtify, Inc. With 20+ years in the drug and medical device industries, Tadikonda has a deep understanding of drug discovery and development processes, significant experience with global clinical and regulatory submission standards, and has been actively involved in leading and participating in the development of electronic standards for the industry. Prior to Virtify, Tadikonda founded companies focused on electronic data capture and R&D systems integration and held senior management positions with leading companies in the pharmaceutical and medical device industries.

About Virtify

Virtify is the market leader in Enterprise Content Compliance solutions for Life Sciences. Organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's easy-to-use Virtx software suite is the industry's only solution to provide a secure, collaborative web-based environment for managing regulated content throughout the entire continuum -- from pre-clinical through product registration to commercialization. The company plays a leadership role in the development of global regulatory standards and is an active participant in a variety of standards committees. Virtify's software products, combined with comprehensive professional services and deep domain expertise enhance quality and compliance for some of the world's leading life sciences companies.

Virtify is headquartered in Cambridge, Massachusetts (USA) with facilities in Europe and Asia. For more information, visit www.virtify.com

About Pilgrim Software, Inc.

Pilgrim Software, Inc. is a world-leading provider of Enterprise Compliance and Quality Management solutions for global organizations. Named 2007 & 2008 North American Enterprise Compliance & Quality Management Company of the Year by Frost & Sullivan, Pilgrim helps organizations manage industry and regulatory compliance, reduce manufacturing costs and improve customer satisfaction. For more information, visit Pilgrim Software's website at www.pilgrimsoftware.com.


'/>"/>
SOURCE Virtify, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
2. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
3. Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis
4. Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis
5. Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
6. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
7. IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its Embracing Human Technology Interactions Media Event
8. The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment
9. Ecologists propose first prevention for white-nose syndrome death in bats
10. White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers
11. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... DUBLIN , Jan 19, 2017 Research ... Market by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity ... ... Report, forecasts that the global market is projected to reach $15,737 ... of 13% from 2016 to 2022. Omic technologies ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... announced the formation of its Medical/Clinical Advisory Board. ... industry veterans who enhance the range and depth ... development of its novel prenatal diagnostic tests.  These ... and strategic guidance for the company,s product development ...
(Date:1/19/2017)... Research and Markets ... has announced the addition of the ... 2025" report to their offering. Report ... provides a detailed analysis on current and future market trends to identify ... market values as the base numbers Key market trends ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... software to leading biopharmaceutical and medical device manufacturers and regulators, is proud to ... CFR Part 11-compliant email client designed to provide product vigilance departments with the ...
Breaking Biology Technology:
(Date:12/15/2016)... Dec. 15, 2016   WaferGen Bio-systems, Inc. ... technology company, announced today that on December 13, 2016, ... of The Nasdaq Stock Market LLC which acknowledged that, ... of WaferGen,s common stock had been at $1.00 or ... regained compliance with Listing Rule 5550(a)(2) of the Nasdaq ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the growth of ... expected to grow from USD 4.03 billion in 2015 ... of 29.3% between 2016 and 2022. The market is ... smart devices, government initiatives, and increasing penetration of e-commerce ... to grow at a high rate during the forecast ...
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):